382 related articles for article (PubMed ID: 3018528)
1. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
Reisman D; Yates J; Sugden B
Mol Cell Biol; 1985 Aug; 5(8):1822-32. PubMed ID: 3018528
[TBL] [Abstract][Full Text] [Related]
2. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
Reisman D; Sugden B
Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
[TBL] [Abstract][Full Text] [Related]
3. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
Chittenden T; Lupton S; Levine AJ
J Virol; 1989 Jul; 63(7):3016-25. PubMed ID: 2542609
[TBL] [Abstract][Full Text] [Related]
4. The minimal replicator of Epstein-Barr virus oriP.
Yates JL; Camiolo SM; Bashaw JM
J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
[TBL] [Abstract][Full Text] [Related]
5. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
Kirchmaier AL; Sugden B
J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
[TBL] [Abstract][Full Text] [Related]
6. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
Kirchmaier AL; Sugden B
J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
[TBL] [Abstract][Full Text] [Related]
7. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
Wysokenski DA; Yates JL
J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
Orlowski R; Miller G
J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
[TBL] [Abstract][Full Text] [Related]
9. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
Platt TH; Tcherepanova IY; Schildkraut CL
J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
[TBL] [Abstract][Full Text] [Related]
10. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
Lupton S; Levine AJ
Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
[TBL] [Abstract][Full Text] [Related]
11. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
Aiyar A; Tyree C; Sugden B
EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
[TBL] [Abstract][Full Text] [Related]
12. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
Koons MD; Van Scoy S; Hearing J
J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
[TBL] [Abstract][Full Text] [Related]
13. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
Harrison S; Fisenne K; Hearing J
J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
[TBL] [Abstract][Full Text] [Related]
14. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Puglielli MT; Woisetschlaeger M; Speck SH
J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
[TBL] [Abstract][Full Text] [Related]
15. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
Dhar V; Schildkraut CL
Mol Cell Biol; 1991 Dec; 11(12):6268-78. PubMed ID: 1658629
[TBL] [Abstract][Full Text] [Related]
16. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
Leight ER; Sugden B
J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
[TBL] [Abstract][Full Text] [Related]
17. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
Tsang SF; Wang F; Izumi KM; Kieff E
J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.
Hearing J; Mülhaupt Y; Harper S
J Virol; 1992 Feb; 66(2):694-705. PubMed ID: 1309908
[TBL] [Abstract][Full Text] [Related]
19. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
Julien MD; Polonskaya Z; Hearing J
Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
[TBL] [Abstract][Full Text] [Related]
20. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
